73 related articles for article (PubMed ID: 21910336)
1. [Effect of xunxi no.1 intervention and radiotherapy on Ia-IIb stage cervical cancer with high-risk human papilloma virus infection].
Zhang PY; Liu L; Wang XB
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1066-9. PubMed ID: 21910336
[TBL] [Abstract][Full Text] [Related]
2. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of human papillomavirus viral load in correlation with different therapeutic modalities in cervical cancer patients.
Cao M; Shah W; Qi J; Zhou Y; Wang Y; Chen H
Pathol Res Pract; 2016 Sep; 212(9):804-10. PubMed ID: 27461827
[TBL] [Abstract][Full Text] [Related]
4. Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma.
Park TK; Kwon JY; Kim SW; Kim SH; Kim SN; Kim GE
Int J Clin Oncol; 2004 Apr; 9(2):120-4. PubMed ID: 15108044
[TBL] [Abstract][Full Text] [Related]
5. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA.
Kornovski Y; Gorchev G
J BUON; 2006; 11(3):291-7. PubMed ID: 17309152
[TBL] [Abstract][Full Text] [Related]
7. Expression of high-risk HPV DNA and CK19 in pelvic lymph nodes in stage Ia-IIa cervical cancer and their clinical value.
Zhang F; Liu D; Lin B; Hao Y; Zhou D; Qi Y; Zhang S
Oncol Rep; 2012 Jun; 27(6):1801-6. PubMed ID: 22407186
[TBL] [Abstract][Full Text] [Related]
8. HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
Lee YS; Rhim CC; Lee HN; Lee KH; Park JS; Namkoong SE
Gynecol Oncol; 2007 May; 105(2):351-7. PubMed ID: 17275890
[TBL] [Abstract][Full Text] [Related]
9. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic efficacy of youdujing preparation in treating cervical high-risk human papilloma virus infection patients].
Xiao J; Wu J; Yu B
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Sep; 32(9):1212-5. PubMed ID: 23185761
[TBL] [Abstract][Full Text] [Related]
11. Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography.
Yoon MS; Ahn SJ; Nah BS; Chung WK; Song HC; Yoo SW; Song JY; Jeong JU; Nam TK
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e491-7. PubMed ID: 22818418
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Chinese materia medica combined chemotherapy on the survivals of stage II and III colorectal cancer].
Lu XM; Zheng J; Zhu YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Sep; 32(9):1166-70. PubMed ID: 23185751
[TBL] [Abstract][Full Text] [Related]
13. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
14. [Progress of study on anti-human cervical papilloma virus infection with Chinese and Western medicine].
Li MC; Liu W; Shao WR
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jun; 27(6):573-5. PubMed ID: 17633379
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
[TBL] [Abstract][Full Text] [Related]
16. HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.
Wang CC; Lai CH; Huang YT; Chao A; Chou HH; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e499-506. PubMed ID: 22889667
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I
Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of human papillomavirus type 58 in Chinese patients with cervical carcinoma and its influence on survival.
Shah W; Hongwei C; Jin Z; Lifang D; Jun Y; Yili W
Clin Oncol (R Coll Radiol); 2009 Dec; 21(10):768-74. PubMed ID: 19875274
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy.
Kodama J; Seki N; Nakamura K; Hongo A; Hiramatsu Y
Gynecol Oncol; 2007 Jun; 105(3):757-61. PubMed ID: 17433424
[TBL] [Abstract][Full Text] [Related]
20. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]